CDKN2A and acute lymphoblastic leukemia: The proportion of T-ALL patients in the CDKN2A/B deletion group was significantly greater than that in the non-deletion group, suggesting that CDKN2A/B deletion occurred more frequently in T-ALL patients than in B-ALL patients.